118 related articles for article (PubMed ID: 10989734)
1. [The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension].
Hanon O; Franconi G; Mourad JJ; Baleydier A; Croce I; Girerd X
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):943-7. PubMed ID: 10989734
[TBL] [Abstract][Full Text] [Related]
2. [Are the 1999 World Health Organization-International Society of Hypertension recommendations applicable to clinical practice?].
Hanon O; Anagnostopoulos K; Franconi G; Amah G; Safar M; Girerd X
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):953-7. PubMed ID: 10989736
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
5. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
6. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
Hanon O; Hoguin JC; Girerd X
Arch Mal Coeur Vaiss; 2003; 96(7-8):744-7. PubMed ID: 12945215
[TBL] [Abstract][Full Text] [Related]
7. [Arterial hypertension management in general practice in France according to global risk factors].
Amar J; Vaur L; Perret M; Bailleau C; Etienne S; Chamontin B
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):843-5. PubMed ID: 11575215
[TBL] [Abstract][Full Text] [Related]
8. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular risk among patients of general practices, who are not in current acute care].
Jancsó Z; Márton H; Simay A; Ujhelyi I; Ilyés I
Orv Hetil; 2003 Jul; 144(29):1433-9. PubMed ID: 12939864
[TBL] [Abstract][Full Text] [Related]
11. [Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Evaluation and stratification of cardiovascular risk based on the 2000 ANAES recommendations in a population of hypertensive patients].
Mounier-Vehier C; Amah G; Covillard J; Jaboureck O; Phan TM
Arch Mal Coeur Vaiss; 2002; 95(7-8):667-72. PubMed ID: 12365077
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Rosolová H; Cech J; Sefrna F
Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
[TBL] [Abstract][Full Text] [Related]
15. Lack of control of high blood pressure and treatment recommendations in Canada.
Khan N; Chockalingam A; Campbell NR
Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
[TBL] [Abstract][Full Text] [Related]
16. A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients.
Fahey TP; Peters TJ
Br J Gen Pract; 1996 Nov; 46(412):655-9. PubMed ID: 8978111
[TBL] [Abstract][Full Text] [Related]
17. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
18. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
19. [Blood pressure control after a one year follow-up in high risk subject screened in occupational medicine].
Cambou JP; Cothereau C; Chatellier G; Saliou P; Thomas D; Capron L
Arch Mal Coeur Vaiss; 2005; 98(7-8):789-93. PubMed ID: 16220749
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risk and the measurement of arterial pressure].
Vaisse B; Silhol F; Bouchlagem K; Maximovitch A; Poggi L
Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():9-12. PubMed ID: 9805563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
